Joinn Laboratories(China)Co.,Ltd. (HKG:6127)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.14
-0.06 (-0.42%)
Jun 6, 2025, 3:45 PM HKT
69.95%
Market Cap 14.63B
Revenue (ttm) 2.12B
Net Income (ttm) 415.38M
Shares Out n/a
EPS (ttm) 0.55
PE Ratio 35.22
Forward PE 58.77
Dividend 0.18 (1.26%)
Ex-Dividend Date Jun 28, 2024
Volume 5,192,482
Average Volume 9,529,830
Open 14.30
Previous Close 14.20
Day's Range 13.78 - 14.46
52-Week Range 6.31 - 17.60
Beta 0.73
RSI 66.41
Earnings Date Aug 29, 2025

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I cli... [Read more]

Sector Healthcare
Founded 1995
Employees 2,652
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6127
Full Company Profile

Financial Performance

In 2024, HKG:6127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.